The Hindu Businessline

Anupam Rasayan completes purchase of 48.2% stake in Bliss GVS Pharma for 1,750 cr

The controlling stake was acquired via the promoter/Share Purchase Agreement (SPA) route at 299 per share, plus an open offer and a small on-market top-up.